Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Larder

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|December 1, 1992
3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitorsB A Larder
The Journal of General Virology|May 1, 1994
Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptaseB A Larder
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
Viral resistance and the selection of antiretroviral combinationsB A Larder
Research in Virology|March 1, 1992
The clinical significance of antiviral drug resistanceG Darby, B A Larder
Antiviral Research|April 1, 1984
Virus drug-resistance: mechanisms and consequencesB A Larder, G Darby
Journal of Virology|May 1, 1982
Properties of a novel thymidine kinase induced by an acyclovir-resistant herpes simplex virus type 1 mutantB A Larder, G Darby
Virology|October 30, 1985
Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activitiesB A Larder, G Darby
Antiviral Therapy|October 27, 2001
Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposureV Miller, B A Larder
Antimicrobial Agents and Chemotherapy|January 1, 1994
Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolatesP Kellam, B A Larder
Antimicrobial Agents and Chemotherapy|May 1, 1986
Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovirB A Larder, G Darby
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|December 1, 1992
3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitorsB A Larder
The Journal of General Virology|May 1, 1994
Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptaseB A Larder
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
Viral resistance and the selection of antiretroviral combinationsB A Larder
Research in Virology|March 1, 1992
The clinical significance of antiviral drug resistanceG Darby, B A Larder
Antiviral Research|April 1, 1984
Virus drug-resistance: mechanisms and consequencesB A Larder, G Darby
Journal of Virology|May 1, 1982
Properties of a novel thymidine kinase induced by an acyclovir-resistant herpes simplex virus type 1 mutantB A Larder, G Darby
Virology|October 30, 1985
Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activitiesB A Larder, G Darby
Antiviral Therapy|October 27, 2001
Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposureV Miller, B A Larder
Antimicrobial Agents and Chemotherapy|January 1, 1994
Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolatesP Kellam, B A Larder
Antimicrobial Agents and Chemotherapy|May 1, 1986
Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovirB A Larder, G Darby
Pageof 8